HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$197.67
Day range
$193.21 - $198.90
Year range
$114.53 - $208.16
Market cap
11.81B USD
Avg Volume
512.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 158.04M | 339.04% |
Operating expense | 179.55M | 13.79% |
Net income | -38.86M | 64.48% |
Net profit margin | -24.58 | 91.91% |
Earnings per share | -0.64 | 66.49% |
EBITDA | -48.64M | 62.25% |
Effective tax rate | -10.99% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 494.05M | 90.98% |
Total assets | 1.09B | 43.47% |
Total liabilities | 1.28B | 18.16% |
Total equity | -187.57M | — |
Shares outstanding | 60.55M | — |
Price to book | -63.76 | — |
Return on assets | -12.32% | — |
Return on capital | -20.97% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -38.86M | 64.48% |
Cash from operations | -7.34M | 88.03% |
Cash from investing | -4.34M | -813.49% |
Cash from financing | 6.98M | 384.36% |
Net change in cash | -23.88M | 61.20% |
Free cash flow | -2.00M | 96.40% |
About
Founded
2006
Website
Employees
1,017
